The V Synergistic Meeting on Oligonucleotide Therapeutics (SMOT V) returns to Valencia as the premier international forum for researchers, industry leaders, and pioneers in the field of therapeutic oligonucleotides.
This fifth edition focuses specifically on “Platform approaches and drug development acceleration,” exploring how integrated technologies and academic-industrial partnerships are shortening the path from discovery to clinical application. Across two intensive days of networking and high-level scientific exchange, SMOT V provides the ideal ecosystem to showcase breakthroughs in chemical diversity, manufacturing, and regulatory milestones that are shaping the future of medicine.